LifeSci Accelerate Finds its Audience: Early Successes and Growing Momentum

August 26, 2022

One month after launch, the LifeSci Accelerate search offering for early-stage biotechs is already producing wins for clients. We’ll bring the program to industry events in Q3 and Q4 of this year.

Women’s Equality Day: An Exploration in Equity in Today’s Life Sciences Industry

August 24, 2022

Four women at LifeSci Search unpack gender equity in the life sciences industry in honor of Women’s Equality Day. Continue reading to learn more!

From Search to Specialization: Lydia Swanson Steps up to Lead Client Strategy & Relationship-Building 

July 27, 2022

We are eager to announce the appointment of Lydia Swanson to LifeSci Search’s newly created role: Director of Strategic Content! Learn more about Lydia, her experience, and how this new role benefits our clients:

How to Assess the Shelf Life of a Biotech Founder

July 27, 2022

Discover what makes an exceptional leader in the biotech sector and when it might be time to transition a founder out.

Personal, Convenient, Powerful: the Future of the European Digital Health Market 

July 27, 2022

In the last five years, digital healthcare has experienced industry-defining innovation – shaping the future of global medicine. Discover the branches of digital health making the most significant impact – particularly in the European market.

What Investors Are Saying About Pricing, Confidence, and the Future of Biotech Stocks

June 29, 2022

Investors are removing money from biotech funds, are being lukewarm on IPOs, and have been doubtful of some startups – but why?

Announcing LifeSci Search Accelerate: The Only Executive Search Offering Priced for Early-Round Startups

June 29, 2022

For early-round startups, attracting and hiring exceptional executive talent is required. Yet, partnering with an external agency may not be financially viable. Enter LifeSci Search Accelerate!

What You Should Be Doing (But Aren’t) to Attract & Retain Talent

June 29, 2022

From our vantage point, many biotech and biopharma firms struggling with talent attraction and retention have three commonalities. Discover what they are—but more importantly—what you can do.

Transformation, Innovation, Culture, and Crisis: Why Your CHRO Belongs On Your Board

June 29, 2022

CHROs and other relative roles such as CPOs deserve a spot on your Board – particularly given the immense focus on talent attraction and retention currently.

Psychedelics: The Current State of Play

May 29, 2022

Psychedelics have explosive potential in the mental health space, but strong market optimism is balanced by institutional wariness – and even bias.